Providing voucher support or pilot grants to researchers to help access resources to generate pilot and preliminary data is a vital component of UMB’s mission to remove barriers to clinical translational research that will improve the health of our Baltimore community, Maryland, and the Mid-Atlantic region.
Please Note! If you are seeking biostatistics, community collaboration/engagement consultation, dissemination/implementation expertise, drug discovery/development expertise, informatics (clinical data, REDCap services), or a studio, please visit our Investigator Resources page https://www.umaryland.edu/ictr/investigator-resources/.
UMB ICTR CTSA Pilot Grant and Voucher (micro-grant) Funding Opportunities
Pilot Grant Opportunities
Community Engaged Research (CEnR) Grant Program. Awards up to $50,000. Application Deadline for 2024-2025 Funding Period is Friday, November 10, 2023, 5 pm (Eastern Time)
Accelerated Translational Incubator Pilot (ATIP) Grant Program. Awards up to $50,000. Application Deadline for 2024-2025 Funding Period is Friday, November 10, 2023, 5 pm (Eastern Time)
Voucher (micro-grant) Program
Voucher Program to help defray cost of UMB fee-for-service cores. Up to $5000. Applications accepted quarterly.
CEnR Voucher Program. Up to $10,000 to support preparatory work of developing sustainable community partnership(s) for future CEnR-type pilot grant applications. Applications accepted semi-annually.
All publications, abstracts, poster presentations, grant applications, intellectual property disclosures resulting from research supported by the UMB ICTR Cores (Biostatistics, Informatics, Community Collaboration, Dissemination & Implementation, and Drug Discovery and Development); ICTR Vouchers Program, ICTR Studios consulting service; Pilot grant funding; or the ICTR Scholar's Program should cite the University of Maryland, Baltimore, Institute for Clinical & Translational Research as a contributing source of support. Please include the following citation:
“We acknowledge the support of the University of Maryland, Baltimore, Institute for Clinical & Translational Research (ICTR) and the National Center for Advancing Translational Sciences (NCATS) Clinical Translational Science Award (CTSA) grant number UL1TR003098.”
The University of Maryland, Baltimore (UMB) and Johns Hopkins University (JHU) forge a powerful alliance with the National Institutes of Health (NIH) Clinical and Translational Science Award (CTSA). As a CTSA Program hub (UL1TR003098-01), UMB now has additional NIH U01 and R21 funding opportunities that would not otherwise be available.
- CCIA U01 Collaborative Innovation Award support investigators from three or more CTSA Program hub institutions
- R21 Exploratory/Developmental Innovation Awards support investigators from two or more CTSA Program hub institutions to either:
1) form new collaborations, or to
2) significantly expand the scientific scope of existing collaborations, or to
3) engage new collaborators in pre-existing collaborations to solve a translational science problem no one hub can solve alone, or disseminate a solution to a translational science problem developed at one hub to other hubs, in so doing testing its robustness to different hub environments and structures and adapting it for further dissemination within outside the CTSA Program consortium if appropriate.
Please visit the CTSA FAQ page for information https://ncats.nih.gov/ctsa/funding/innovation-faq#par
NIH Tips on Writing a Research Proposal
The NIH has information about writing research proposals at https://grants.nih.gov/grants/how-to-apply-application-guide/format-and-write/write-your-application.htm